Safety, Efficacy and Dose-response Study of BMS-986001 in Subjects With HIV-1 Infection Who Are Treatment-naive
Public ClinicalTrials.gov record NCT01489046. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase IIb Randomized, Controlled, Partially Blinded Clinical Trial to Investigate Safety, Efficacy and Dose-response of BMS-986001 in Treatment-naive HIV-1-infected Subjects, Followed by an Open-label Period on the Recommended Dose
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of this study is to identify at least one dose of BMS-986001 which is safe, well tolerated, and efficacious when combined with Efavirenz (EFV) + Lamivudine (3TC) for treatment-naive Human Immunodeficiency Virus 1 (HIV-1) infected subjects
Study identification
- NCT ID
- NCT01489046
- Recruitment status
- Terminated
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 297 participants
Conditions and interventions
Conditions
Interventions
- BMS-986001 Drug
- Placebo matching with BMS-986001 Drug
- Efavirenz Drug
- Lamivudine Drug
- Tenofovir Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jan 31, 2011
- Primary completion
- Feb 28, 2013
- Completion
- Jun 30, 2014
- Last update posted
- Apr 14, 2016
2011 – 2014
United States locations
- U.S. sites
- 18
- U.S. states
- 11
- U.S. cities
- 18
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Uc Davis Medical Center | Sacramento | California | 95817 | — |
| Orlando Immunology Center | Orlando | Florida | 32803 | — |
| Triple O Medical Services, P.A. | West Palm Beach | Florida | 33401 | — |
| Aids Research Consortium Of Atlanta | Atlanta | Georgia | 30308 | — |
| Indiana University | Indianapolis | Indiana | 46202 | — |
| Local Institution | Washingtondc | Maryland | 20009 | — |
| Clinic 42 And International Travel Clinic | Minneapolis | Minnesota | 55404 | — |
| University At Buffalo | Buffalo | New York | 14215 | — |
| Local Institution | New York | New York | 10011 | — |
| Jacobi Medical Center | The Bronx | New York | 10461 | — |
| Local Institution | Charlotte | North Carolina | 28209 | — |
| University Of Pennsylvania | Philadelphia | Pennsylvania | 19104 | — |
| Local Institution | Columbia | South Carolina | 29203 | — |
| Central Texas Clinical Research | Austin | Texas | 78705 | — |
| St. Hope Foundation | Bellaire | Texas | 77401 | — |
| North Texas Infectious Disease Consultants | Dallas | Texas | 75246 | — |
| Tarrant County Infectious Disease Associates | Fort Worth | Texas | 76104 | — |
| Therapeutic Concepts, P.A. | Houston | Texas | 77004 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 33 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01489046, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Apr 14, 2016 · Synced Sep 11, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT01489046 live on ClinicalTrials.gov.